Kalyan Das, PhD
Kalyan Das joined the Department of Medical Microbiology and Immunology, 伊人直播 as a professor and Canada Excellence Research Chair (CERC). His research focuses on the fundamental understanding of molecular machines in pathogens, identifying novel target sites, understanding mechanisms of drug resistance, and utilizing this information in designing new drug candidates. He is helping to build a structure-based drug design platform using the cryogenic electron microscopy (cryo-EM) technique and will work with interdisciplinary teams to develop antivirals and vaccine candidates. He has been working on developing antivirals targeting the replication machinery of viruses such as HIV, hepatitis, Influenza, dengue, and SARS-CoV-2.